Login / Signup

Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza.

Ekaterina StepanovaIrina Isakova-SivakLarisa Rudenko
Published in: Expert review of vaccines (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus